Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Daily transcutaneous tibial nerve stimulation to improve bladder emptying in multiple sclerosis

Official title: Efficacy and Safety of Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis Patients.

Run by University Hospital, Lille · NCT04573673 · Data updated 2026-11-12

This trial will test whether daily transcutaneous tibial neurostimulation for 30 minutes over 12 weeks can improve bladder emptying in people with multiple sclerosis who use clean intermittent self-catheterization.

More Multiple Sclerosis trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment68 (estimated)
SponsorUniversity Hospital, Lille
Academic / other
Locations1 site (Lille)
StatusRecruiting
StartedDecember 1, 2021
Main results expectedJune 2026
Study endsJune 2026
Registry record updatedDecember 23, 2025
Trial IDNCT04573673 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people with multiple sclerosis and bladder-sphincter dyssynergia who rely exclusively on clean intermittent self-catheterization, have EDSS below 6, and have not recently received tibial stimulation, sacral neuromodulation, or botulinum toxin A.

Probably not a fit

Patients with other neurological diseases, EDSS ≥ 6, recurrent urinary tract infections, uncontrolled detrusor overactivity or bladder compliance disorders, recent tibial or sacral neuromodulation, or recent botulinum toxin or alpha-blocker treatment are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with multiple sclerosis and bladder-sphincter dyssynergia who empty their bladder using clean intermittent self-catheterization are randomized to receive either active transcutaneous tibial neurostimulation or a placebo (no current) for 30 minutes daily over 12 weeks. The primary outcome is change in bladder voiding efficiency (BVE ratio) measured 12 weeks after randomization. Safety and tolerability are monitored during the treatment period. The control arm follows the same schedule with sham stimulation to blind participants.

Why it matters

Potential benefit: If successful, the treatment could improve bladder emptying and reduce incomplete voiding for people with MS who use self-catheterization.

How similar studies have gone: Tibial nerve stimulation and percutaneous tibial nerve stimulation have shown benefit for overactive bladder in prior studies, but evidence specifically for improving voiding dysfunction in MS patients is limited and mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient with a diagnosis of multiple sclerosis
* Patient with bladder-sphincter dyssinergia
* Patient using clean intermittent self-catheterization as exclusive bladder management
* Patient who has given written consent
* Socially insured patient
* Patient willing to comply with all study procedures and study duration

Exclusion Criteria:

* Patient with other associated neurological pathology
* Patient with an Expanded Disability Status Scale (EDSS) score ≥ 6
* Patient with recurrent urinary tract infections (\> 3 episodes / year)
* Patient with uncontrolled overactive bladder
* Patient with uncontrolled detrusor hyperactivity
* Patient with a bladder compliance disorder
* Patient with tibial neuro-stimulation in the last 3 months
* Patient treated with a sacral neuro-modulation
* Patient who has received an intradermal injection of botulinum toxin A within the last 9 -months Patient who received alpha-blocker treatment within the last month Patient with benign prostatic hypertrophy (prostate volume \> 40 cc) - Last ultrasound scan \< 6 months.

Patient with one or more bladder diverticulum(s) Patient with unilateral or bilateral renal Patient with unilateral or bilateral vesico-ureteral reflux Patient with impaired renal function (GFR according to CKD-EPI \< 60 ml/min/1.73m2) Patient with a metallic prosthesis on the lower limb Patient with a Pacemaker Pregnant patient

Where it's running

  • Hop Claude Huriez Chu Lille
    Lille, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.